Journal Article

Recommendations and low-technology safety solutions following neuromuscular blocking agent incidents.

Graudins L, Downey G, Bui T, et al. Joint Commission journal on quality and patient safety. 2016;42:86-91.

Administration errors involving high-alert medications have the potential to cause serious patient harm. This commentary discusses one hospital's effort to reduce errors associated with neuromuscular blocking agents. The authors used root cause analysis to identify weaknesses in labeling, storage, and packaging methods, and implemented guidelines to reduce risk of errors involving such medications.